Literature DB >> 20926326

Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein.

Kpandja Djawe1, Kieran R Daly, Sergio L Vargas, M Elena Santolaya, Carolina A Ponce, Rebeca Bustamante, Judith Koch, Linda Levin, Peter D Walzer.   

Abstract

OBJECTIVES: To characterize the seroepidemiological features of Pneumocystis jirovecii infection in healthy Chilean children using overlapping fragments (A, B, C) of the P. jirovecii major surface glycoprotein (Msg).
METHODS: Serum antibodies to MsgA, MsgB, and MsgC were measured every 2 months by enzyme-linked immunosorbent assay (ELISA) in 45 Chilean infants from about age 2 months to 2 years.
RESULTS: Peak antibody levels (usually reached at age 6 months) and the force (or rate) of infection were somewhat greater for MsgC than for MsgA. Significant seasonal variation in antibody levels was only found with MsgA. Respiratory infections occurred in most children, but nasopharyngeal aspirates were of limited value in detecting the organism. In contrast, serological responses commonly occurred, and higher levels only to MsgC were significantly related to the number of infections.
CONCLUSIONS: Serological responses to recombinant Msg fragments provide new insights into the epidemiological and clinical features of P. jirovecii infection of early childhood. MsgA, the amino terminus fragment, is more sensitive in detecting seasonal influences on antibody levels, whereas MsgC is better able to detect changes in antibody levels in response to clinical infection.
Copyright © 2010 International Society for Infectious Diseases. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926326      PMCID: PMC2995006          DOI: 10.1016/j.ijid.2010.07.003

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  45 in total

Review 1.  Immunological features of Pneumocystis carinii infection in humans.

Authors:  P D Walzer
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Helicobacter pylori heat shock protein A: serologic responses and genetic diversity.

Authors:  E K Ng; S A Thompson; G I Pérez-Pérez; I Kansau; A van der Ende; A Labigne; J J Sung; S C Chung; M J Blaser
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia.

Authors:  A Angeloni; L Heston; S Uccini; M C Sirianni; F Cottoni; M V Masala; D Cerimele; S F Lin; R Sun; M Rigsby; A Faggioni; G Miller
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

4.  Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting.

Authors:  R R Taylor; A Egan; D McGuinness; A Jepson; R Adair; C Drakely; E Riley
Journal:  Int Immunol       Date:  1996-06       Impact factor: 4.823

5.  Epidemiologic patterns of upper respiratory illness and Pneumocystis carinii pneumonia in homosexual men.

Authors:  D R Hoover; N M Graham; H Bacellar; L K Schrager; R Kaslow; B Visscher; R Murphy; R Anderson; A Saah
Journal:  Am Rev Respir Dis       Date:  1991-10

6.  Serologic responses to Pneumocystis carinii antigens in health and disease.

Authors:  S L Peglow; A G Smulian; M J Linke; C L Pogue; S Nurre; J Crisler; J Phair; J W Gold; D Armstrong; P D Walzer
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

7.  Multiple genes encode the major surface glycoprotein of Pneumocystis carinii.

Authors:  J A Kovacs; F Powell; J C Edman; B Lundgren; A Martinez; B Drew; C W Angus
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

8.  Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response.

Authors:  S A Theus; A G Smulian; P Steele; M J Linke; P D Walzer
Journal:  Vaccine       Date:  1998-07       Impact factor: 3.641

9.  Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat.

Authors:  S A Theus; R P Andrews; P Steele; P D Walzer
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Molecular characterization of clustered variants of genes encoding major surface antigens of human Pneumocystis carinii.

Authors:  T R Garbe; J R Stringer
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

View more
  15 in total

1.  High transient colonization by Pneumocystis jirovecii between mothers and newborn.

Authors:  Cristian Vera; Yudy A Aguilar; Lázaro A Vélez; Zulma Vanessa Rueda
Journal:  Eur J Pediatr       Date:  2017-09-14       Impact factor: 3.183

Review 2.  The ecology of pneumocystis: perspectives, personal recollections, and future research opportunities.

Authors:  Peter D Walzer
Journal:  J Eukaryot Microbiol       Date:  2013-09-03       Impact factor: 3.346

Review 3.  Colonization by Pneumocystis jirovecii and its role in disease.

Authors:  Alison Morris; Karen A Norris
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

4.  Selective ablation of lung epithelial IKK2 impairs pulmonary Th17 responses and delays the clearance of Pneumocystis.

Authors:  Nelissa Perez-Nazario; Javier Rangel-Moreno; Michael A O'Reilly; Manolis Pasparakis; Francis Gigliotti; Terry W Wright
Journal:  J Immunol       Date:  2013-09-27       Impact factor: 5.422

5.  Serum antibody levels to the Pneumocystis jirovecii major surface glycoprotein in the diagnosis of P. jirovecii pneumonia in HIV+ patients.

Authors:  Kpandja Djawe; Laurence Huang; Kieran R Daly; Linda Levin; Judy Koch; Alexandra Schwartzman; Serena Fong; Brenna Roth; Anuradha Subramanian; Katherine Grieco; Leah Jarlsberg; Peter D Walzer
Journal:  PLoS One       Date:  2010-12-09       Impact factor: 3.240

6.  Humoral immune responses to Pneumocystis jirovecii antigens in HIV-infected and uninfected young children with pneumocystis pneumonia.

Authors:  Kpandja Djawe; Kieran R Daly; Linda Levin; Heather J Zar; Peter D Walzer
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

7.  Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV+ patients.

Authors:  Robert J Blount; Kieran R Daly; Serena Fong; Emily Chang; Katherine Grieco; Meredith Greene; Stephen Stone; John Balmes; Robert F Miller; Peter D Walzer; Laurence Huang
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

Review 8.  Pneumocystis jirovecii colonization in Chronic Obstructive Pulmonary Disease (COPD).

Authors:  S Khodavaisy; E Mortaz; F Mohammadi; M Aliyali; H Fakhim; H Badali
Journal:  Curr Med Mycol       Date:  2015-03

9.  Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.

Authors:  Robert J Blount; Leah G Jarlsberg; Kieran R Daly; William Worodria; J Lucian Davis; Adithya Cattamanchi; Kpandja Djawe; Alfred Andama; Judith Koch; Peter D Walzer; Laurence Huang
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

Review 10.  Pneumocystis jirovecii--from a commensal to pathogen: clinical and diagnostic review.

Authors:  Magdalena Sokulska; Marta Kicia; Maria Wesołowska; Andrzej B Hendrich
Journal:  Parasitol Res       Date:  2015-08-19       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.